Related Experiment Video
Updated: Jun 21, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response
Benjamin M N Kagina1, Brian Abel, Mark Bowmaker
1South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Diseases and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Insights
Delaying the bacillus Calmette-Guérin (BCG) vaccine from birth to 10 weeks enhances infant immune responses. This delayed vaccination leads to improved T cell responses against tuberculosis (TB) at one year of age.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Bacillus Calmette-Guérin (BCG) is a crucial vaccine for preventing severe tuberculosis (TB) in infants, typically administered at birth.
- The neonatal immune system is not fully mature at birth, potentially limiting the efficacy of early-life vaccinations.
Purpose of the Study:
- To investigate whether delaying BCG vaccination from birth to 10 weeks of age improves the vaccine-induced immune response in infants.
- To compare the quantitative and qualitative T cell responses between infants receiving BCG at birth versus at 10 weeks of age.
Main Methods:
- A randomized clinical trial was conducted where infants received BCG intradermally at either birth (n=25) or 10 weeks of age (n=21).
- Vaccine-specific CD4 and CD8 T cell responses were assessed using a whole blood intracellular cytokine assay at 10 weeks post-vaccination and at 1 year of age.
Main Results:
- Infants receiving delayed BCG vaccination showed significantly higher frequencies of BCG-specific CD4 T cells.
- Polyfunctional T cells, co-expressing IFN-gamma, TNF-alpha, and IL-2, were notably increased in the delayed vaccination group.
- These enhanced T cell responses were most pronounced when measured at 1 year of age.
Conclusions:
- Delaying BCG vaccination to 10 weeks of age enhances both the quantity and quality of BCG-specific T cell responses.
- The findings suggest that a delayed BCG vaccination schedule may lead to a more robust and sustained immune response against tuberculosis in early childhood.
Background:
In most tuberculosis (TB) endemic countries, bacillus Calmette-Guérin (BCG) is usually given around birth to prevent severe TB in infants. The neonatal immune system is immature. Our hypothesis was that delaying BCG vaccination from birth to 10 weeks of age would enhance the vaccine-induced immune response.
Methods:
In a randomized clinical trial, BCG was administered intradermally either at birth (n=25) or at 10 weeks of age (n=21). Ten weeks after vaccination, and at 1 year of age, vaccine-specific CD4 and CD8 T cell responses were measured with a whole blood intracellular cytokine assay.
Results:
Infants who received delayed BCG vaccination demonstrated higher frequencies of BCG-specific CD4 T cells, particularly polyfunctional T cells co-expressing IFN-gamma, TNF-alpha and IL-2, and most strikingly at 1 year of age.
Conclusions:
Delaying BCG vaccination from birth to 10 weeks of age enhances the quantitative and qualitative BCG-specific T cell response, when measured at 1 year of age.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines
Cell-mediated Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

